The CDR-H3 repertoire from TdT-deficient adult bone marrow is a close, but not exact, homologue of the CDR-H3 repertoire from perinatal liver

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 6075-6084

  Schelonka, Robert L ^a,f   Ivanov, Ivaylo I ^b,g   Vale, Andre M ^c   Szymanska, Ewa ^b   Zemlin, Michael ^e   Gartland, G Larry ^c   Schroeder Jr , Harry W ^b,c,d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDR H3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULTHOOD; AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; HYDROPHOBICITY; MOLECULAR CLONING; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; BONE MARROW; CELL SEPARATION; COMPLEMENTARITY DETERMINING REGIONS; DNA NUCLEOTIDYLEXOTRANSFERASE; FLOW CYTOMETRY; IMMUNOGLOBULIN HEAVY CHAINS; LIVER; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PRECURSOR CELLS, B-LYMPHOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650638955     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001419     Document Type: Article

References (42)

1. Tonegawa, S. 1983. Somatic generation of antibody diversity. Nature 302:575-581.
2. Alt, F. W., and D. Baltimore. 1982. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc. Natl. Acad. Sci. USA 79:4118-4122.
3. Rajewsky, K., H. Gu, R. Kühn, U. A. Betz, W. Müller, J. Roes, and F. Schwenk. 1996. Conditional gene targeting. J. Clin. Invest. 98:600-603.
4. Hood, L., and D. Galas. 2003. The digital code of DNA. Nature 421:444-448.
5. Nossal, G. J. V. 2003. The double helix and immunology. Nature 421:440-444.
6. Kabat, E. A., T. T. Wu, H. M. Perry, K. S. Gottesman, and C. Foeller. 1991. Sequences of Proteins of Immunological Interest. U. S. Department of Health and Human Services, Bethesda, MD.
7. Padlan, E. A. 1994. Anatomy of the antibody molecule. Mol. Immunol. 31:169-217.
8. Xu, J. L., and M. M. Davis. 2000. Diversity in the CDR3 region of V (H) is sufficient for most antibody specificities. Immunity 13:37-45.
9. Desiderio, S. V., G. D. Yancopoulos, M. Paskind, E. Thomas, M. A. Boss, N. R. Landau, F. W. Alt, and D. Baltimore. 1984. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311:752-755.
10. Komori, T., A. Okada, V. Stewart, and F. W. Alt. 1993. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261:1171-1175.
11. Gilfillan, S., A. Dierich, M. Lemeur, C. Benoist, and D. Mathis. 1993. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 261:1175-1178.
12. Ivanov, I. I., R. L. Schelonka, Y. Zhuang, G. L. Gartland, M. Zemlin, and H. W. Schroeder, Jr. 2005. Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors. J. Immunol. 174:7773-7780.
13. Gu, H., I. Förster, and K. Rajewsky. 1990. Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. EMBO J. 9:2133-2140.
14. Feeney, A. J. 1991. Predominance of the prototypic T15 anti-phosphorylcholine junctional sequence in neonatal pre-B cells. J. Immunol. 147:4343-4350.
15. Schelonka, R. L., E. Szymanska, A. M. Vale, Y. Zhuang, G. L. Gartland, and H. W. Schroeder, Jr. 2010. D (H) and J (H) usage in murine fetal liver mirrors that of human fetal liver. Immunogenetics 62:653-666.
16. Silverstein, A. M. 1977. Ontogeny of the immune response: a perspective. In Development of Host Defense. M. D. Cooper, ed. Raven Press, New York, p. 1-10.
17. Schelonka, R. L., I. I. Ivanov, D. Jung, G. C. Ippolito, L. Nitschke, Y. Zhuang, G. L. Gartland, J. Pelkonen, F. W. Alt, K. Rajewsky, and H. W. Schroeder, Jr. 2005. A single DH gene segment creates its own unique CDR-H3 repertoire and is sufficient for B cell development and immune function. J. Immunol. 175:6624-6632.
18. Ippolito, G. C., R. L. Schelonka, M. Zemlin, I. I. Ivanov, R. Kobayashi, C. Zemlin, G. L. Gartland, L. Nitschke, J. Pelkonen, K. Fujihashi, et al. 2006. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J. Exp. Med. 203:1567-1578.
19. Shirai, H., A. Kidera, and H. Nakamura. 1999. H3-rules: identification of CDR-H3 structures in antibodies. FEBS Lett. 455:188-197.
20. Shirai, H., A. Kidera, and H. Nakamura. 1996. Structural classification of CDR-H3 in antibodies. FEBS Lett. 399:1-8.
21. Schelonka, R. L., J. Tanner, Y. Zhuang, G. L. Gartland, M. Zemlin, and H. W. Schroeder, Jr. 2007. Categorical selection of the antibody repertoire in splenic B cells. Eur. J. Immunol. 37:1010-1021.
22. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595-621.
23. Zemlin, M., R. L. Schelonka, G. C. Ippolito, C. Zemlin, Y. Zhuang, G. L. Gartland, L. Nitschke, J. Pelkonen, K. Rajewsky, and H. W. Schroeder, Jr. 2008. Regulation of repertoire development through genetic control of DH reading frame preference. J. Immunol. 181:8416-8424.
24. Yancopoulos, G. D., S. V. Desiderio, M. Paskind, J. F. Kearney, D. Baltimore, and F. W. Alt. 1984. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature 311:727-733.
25. Huetz, F., L. Carlsson, U. C. Tornberg, and D. Holmberg. 1993. V-region directed selection in differentiating B lymphocytes. EMBO J. 12:1819-1826.
26. Marshall, A. J., G. E. Wu, and G. J. Paige. 1996. Frequency of VH81x usage during B cell development: initial decline in usage is independent of Ig heavy chain cell surface expression. J. Immunol. 156:2077-2084.
27. Williams, G. S., A. Martinez, A. Montalbano, A. Tang, A. Mauhar, K. M. Ogwaro, D. Merz, C. Chevillard, R. Riblet, and A. J. Feeney. 2001. Unequal VH gene rearrangement frequency within the large VH7183 gene family is not due to recombination signal sequence variation, and mapping of the genes shows a bias of rearrangement based on chromosomal location. J. Immunol. 167:257-263.
28. Feeney, A. J. 1992. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. J. Immunol. 149:222-229.
29. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
30. Eisenberg, D. 1984. Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53:595-623.
31. Montecino-Rodriguez, E., H. Leathers, and K. Dorshkind. 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7:293-301.
32. Carvalho, T. L., T. Mota-Santos, A. Cumano, J. Demengeot, and P. Vieira. 2001. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)-mice. J. Exp. Med. 194:1141-1150.
33. Bogan, A. A., and K. S. Thorn. 1998. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280:1-9.
34. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301:1374-1377.
35. Nguyen, H. H., M. Zemlin, I. I. Ivanov, J. Andrasi, C. Zemlin, H. L. Vu, R. L. Schelonka, H. W. Schroeder, Jr., and J. Mestecky. 2007. Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J. Virol. 81:9331-9338.
36. Mahmoud, T. I., and J. F. Kearney. 2010. Terminal deoxynucleotidyl transferase is required for an optimal response to the polysaccharide alpha-1, 3 dextran. J. Immunol. 184:851-858.
37. Feeney, A. J., B. R. Lawson, D. H. Kono, and A. N. Theofilopoulos. 2001. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas (lpr) mice. J. Immunol. 167:3486-3493.
38. Robey, I. F., M. Peterson, M. S. Horwitz, D. H. Kono, T. Stratmann, A. N. Theofilopoulos, N. Sarvetnick, L. Teyton, and A. J. Feeney. 2004. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas (lpr) mice. J. Immunol. 172:4624-4629.
39. Molano, I. D., M. K. Wloch, A. A. Alexander, H. Watanabe, and G. S. Gilkeson. 2000. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas (lpr) mice. Clin. Immunol. 94:24-32.
40. Molano, I. D., S. Redmond, H. Sekine, X. K. Zhang, C. Reilly, F. Hutchison, P. Ruiz, and G. S. Gilkeson. 2003. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clin. Immunol. 107:186-197.
41. Conde, C., S. Weller, S. Gilfillan, L. Marcellin, T. Martin, and J. L. Pasquali. 1998. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White) F1 mice. J. Immunol. 161:7023-7030.
42. Shlomchik, M. J., M. A. Mascelli, H. Shan, M. Z. Radic, D. S. Pisetsky, A. Marshak-Rothstein, and M. G. Weigert. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171:265-292.